Icecure Medical (NASDAQ: ICCM) reported quarterly losses of $(1.37) per share which beat the analyst consensus estimate of $(1.40) by 2.14 percent. This is a 23.89 percent increase over losses of $(1.80) per share from the same period last year. The company reported quarterly sales of $889.000 thousand which missed the analyst consensus estimate of $1.450 million by 38.70 percent. This is a 69.33 percent increase over sales of $525.000 thousand the same period last year.